Deflection of vascular endothelial growth factor action by SS18–SSX and composite vascular endothelial growth factor- and chemokine (C-X-C motif) receptor 4-targeted therapy in synovial sarcoma

Synovial sarcoma (SS) is a malignant soft-tissue tumor characterized by the recurrent chromosomal translocation SS18–SSX. Vascular endothelial growth factor (VEGF)-targeting anti-angiogenic therapy has been approved for soft-tissue sarcoma, including SS; however, the mechanism underlying the VEGF si...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakamatsu, Toru, Naka, Norifumi, Sasagawa, Satoru, Tanaka, Takaaki, Takenaka, Satoshi, Araki, Nobuhito, Ueda, Takafumi, Nishizawa, Yasuko, Yoshikawa, Hideki, Itoh, Kazuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462399/
https://www.ncbi.nlm.nih.gov/pubmed/24975049
http://dx.doi.org/10.1111/cas.12469

Ejemplares similares

Ejemplares similares